Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic

INTRODUCTION: In Europe, the SARS‐CoV‐2 pandemic had its first epicenter in Italy. Despite a significant mortality rate, the severity of most cases of COVID‐19 infection ranges from asymptomatic to mildly symptomatic, and silent infection affects a still‐unknown proportion of the general population....

Descripción completa

Detalles Bibliográficos
Autores principales: Zambelli, Alberto, Chiudinelli, Lorenzo, Fotia, Vittoria, Negrini, Giorgia, Bosetti, Tommaso, Callegaro, Annapaola, Di Croce, Andrea, Caremoli, Elena Rota, Moro, Cecilia, Milesi, Laura, Poletti, Paola, Tasca, Cristina, Mandalà, Mario, Merelli, Barbara, Mosconi, Stefania, Arnoldi, Ermenegildo, Bettini, Anna, Bonomi, Lucia, Messina, Caterina, Ghilardi, Laura, Chirco, Alessandra, Maracino, Michela, Tondini, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018331/
https://www.ncbi.nlm.nih.gov/pubmed/33355953
http://dx.doi.org/10.1002/onco.13654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018331/
https://www.ncbi.nlm.nih.gov/pubmed/33355953
http://dx.doi.org/10.1002/onco.13654

Ejemplares similares